PIPages
Labs

Amy Lasek

Virginia Commonwealth University, VA·Neuroscience

Heavy, repeated drinking reshapes which genes brain cells switch on, and those changes can push someone further toward alcohol use disorder (AUD). Two projects ask how this gene regulation works and whether it can be interrupted.

Fields

Neuroscience

Pharmacology

Genetics

Topics

alcohol use disorder

binge drinking

drinking in the dark

Grants
2 known grants, through May 2030

What they work on

  1. Map alcohol-induced changes in the cortical extracellular matrix, or "matrisome," using quantitative proteomics and glycomics in mice after six weeks of binge-like drinking in the dark, and compare them with transcriptome datasets.
  2. Test whether STAT3, an immune-related transcription factor, acts in astrocytes to drive drinking, by deleting Stat3 with floxed mice and the Aldh1l1-CreERT2 astrocyte Cre line and mapping STAT3 binding sites by ChIP-Seq.
  3. Determine whether brevican, a matrix protein surrounding synapses that regulates plasticity, controls alcohol intake, using astrocyte knockout and viral shRNA in prefrontal cortex plus super-resolution imaging of synaptic markers.
  4. Identify the genome-wide binding sites of the chromatin remodeling subunits SMARCA2 and SMARCA4 in ventral hippocampus before and after chronic binge drinking, using CUT&RUN sequencing integrated with single-nuclei RNA sequencing.
  5. Test the roles of SMARCA2 and SMARCA4 in ethanol consumption, locomotor activation, anxiety reduction and sedation tolerance, using dual small-molecule inhibitors and Cre-dependent viral knockout in the ventral hippocampus.

More about the research

One focuses on the extracellular matrix, the scaffolding of proteins and sugars that surrounds brain cells and helps hold synapses, the connections between neurons, in place. The other focuses on chromatin remodeling, the machinery that opens or closes stretches of DNA so transcription factors can reach their targets. Both use mice that drink alcohol in binge-like patterns, pair genome-wide measurements with targeted gene knockouts, and test effects on how much animals drink.

Why it matters

Alcohol use disorder has few effective medications. These projects aim to pin down specific molecules, the astrocyte transcription factor STAT3, the synapse-surrounding protein brevican, and the chromatin remodeling enzymes SMARCA2 and SMARCA4, that shape how much animals drink. Each could become a target for new drugs to reduce excessive alcohol consumption, and inhibitors of SMARCA2/SMARCA4 already exist as chemical tools.

Known grants

From NIH and NSF research grants. Labs often have other funding we can't see.

Project 3: Chromatin remodeling mechanisms in alcohol use disorder

NIH · Aug 2014 – May 2030

4/11 Neuroimmune and extracellular matrix interactions in alcohol consumption

NIH · Nov 2022 – Jan 2027

Closest labs

Hyung Nam

Louisiana State University Health Sciences Center-Shreveport, LA·Neuroscience

Determine how chronic alcohol lowers neurogranin, a synaptic protein that tunes glutamate signaling, in the mouse medial prefrontal cortex, and test tolerance in mice with mPFC-specific Ng knockout or overexpression.

Samuel Centanni

Wake Forest University, NC·Neuroscience

Test whether stress-driven activity in the insula-BNST pathway predicts later binge and aversion-resistant ethanol drinking, following mouse models of stress and binge drinking over time.

Erbo Dong

Ohio State University, OH·Neuroscience

Determine whether PP1a, an enzyme that promotes HDAC4 build-up in the nucleus, drives the ethanol preference, tolerance and anxiety-like behavior seen in adult mouse offspring of prenatally stressed mothers.

The school

Virginia Commonwealth University: 19 labs on PI Pages, $524M a year on research, 438 research doctorates a year.

More about Virginia Commonwealth University

Reach out

A start for your email. Fill in the brackets.